Evaluation of Novel Large Cut-Off Ultrafiltration Membranes for Adenovirus Serotype 5 (Ad5) Concentration

被引:22
|
作者
Nestola, Piergiuseppe [1 ,2 ]
Martins, Duarte L. [1 ]
Peixoto, Cristina [1 ,2 ]
Roederstein, Susanne [5 ]
Schleuss, Tobias [5 ]
Alves, Paula M. [1 ,2 ]
Mota, Jose P. B. [1 ,3 ]
Carrondo, Manuel J. T. [1 ,4 ]
机构
[1] Inst Biol Expt & Tecnol, P-2781901 Oeiras, Portugal
[2] Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-2780157 Oeiras, Portugal
[3] Univ Nova Lisboa, Requimte CQFB, Dept Quim, Fac Ciencias & Tecnol, P-2829516 Caparica, Portugal
[4] Univ Nova Lisboa, Dept Quim, Fac Ciencias & Tecnol, P-2829516 Caparica, Portugal
[5] Sartorius Stedim Biotech, D-37079 Gottingen, Germany
来源
PLOS ONE | 2014年 / 9卷 / 12期
关键词
TANGENTIAL FLOW FILTRATION; PURIFICATION PROCESS; RETROVIRAL VECTORS; ANION-EXCHANGE; VIRUS; CHROMATOGRAPHY; TECHNOLOGY; MICROFILTRATION; PARTICLES; RECOVERY;
D O I
10.1371/journal.pone.0115802
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The purification of virus particles and viral vectors for vaccine and gene therapy applications is gaining increasing importance in order to deliver a fast, efficient, and reliable production process. Ultrafiltration (UF) is a widely employed unit operation in bioprocessing and its use is present in several steps of the downstream purification train of biopharmaceuticals. However, to date few studies have thoroughly investigated the performance of several membrane materials and cutoffs for virus concentration/diafiltration. The present study aimed at developing a novel class of UF cassettes for virus concentration/ diafiltration. A detailed study was conducted to evaluate the effects of (i) membrane materials, namely polyethersulfone (PES), regenerated cellulose (RC), and highly cross-linked RC (xRC), (ii) nominal cut-off, and (iii) UF device geometry at different production scales. The results indicate that the xRC cassettes with a cut-off of approximately 500 kDa are able to achieve a 10-fold concentration factor with 100% recovery of particles with a process time twice as fast as that of a commercially available hollow fiber. DNA and host cell protein clearances, as well as hydraulic permeability and fouling behavior, were also assessed.
引用
收藏
页数:22
相关论文
共 40 条
  • [21] Genetic Retargeting of Ad5 Using a Novel Class of Ligands (Nanobodies) Belonging to the Immunoglobulin Superfamily and Having a Large Natural Diversity
    Lindholm, Leif
    Magnusson, Maria K.
    Wising, Catharina
    Henning, Petra
    Baty, Daniel
    Chames, Patrick
    Willemsen, Ralph
    MOLECULAR THERAPY, 2009, 17 : S322 - S323
  • [22] Performance evaluation of 5 um cut-off Hawaii-2RG detectors using the fast readout amplifiers
    Ives, Derek
    Finger, Gert
    Dorn, Reinhold
    Eschbaumer, Siegfried
    Mehrgan, Leander
    Meyer, Manfred
    Stegmeier, Joerg
    HIGH ENERGY, OPTICAL, AND INFRARED DETECTORS FOR ASTRONOMY IV, 2010, 7742
  • [23] Chimeric oncolytic adenovirus Ad5/3-hTERT-E1A-CD40L for the treatment of advanced solid tumors: preclinical and clinical evaluation
    Pesonen, S.
    Diaconu, I.
    Cerullo, V.
    Ranki, T.
    Kangasniemi, L.
    Escutenaire, S.
    Kanerva, A.
    Joensuu, T.
    Hemminki, A.
    HUMAN GENE THERAPY, 2011, 22 (10) : A120 - A120
  • [24] P19-47. Novel adenovirus type 5 vaccine platform induces cellular immunity against HIV-1 Gag, Pol, Nef despite the presence of Ad5 immunity
    ES Gabitzsch
    Y Xu
    LH Yoshida
    JP Balint
    A Amalfitano
    FR Jones
    Retrovirology, 6
  • [25] Novel replication-incompetent vector derived from adenovirus type 11 (Ad11) for vaccination and gene therapy: Low seroprevalence and non-cross-reactivity with Ad5
    Holterman, L
    Vogels, R
    van der Vlugt, R
    Sieuwerts, M
    Grimbergen, J
    Kaspers, J
    Geelen, E
    van der Helm, E
    Lemckert, A
    Gillissen, G
    Verhaagh, S
    Custers, J
    Zuijdgeest, D
    Berkhout, B
    Bakker, M
    Quax, P
    Goudsmit, J
    Havenga, M
    JOURNAL OF VIROLOGY, 2004, 78 (23) : 13207 - 13215
  • [26] Anti-tumor immunotherapy despite immunity to adenovirus using a novel adenoviral vector Ad5 [E1-, E2b-]-CEA
    Elizabeth S. Gabitzsch
    Younong Xu
    Joseph P. Balint
    Zachary C. Hartman
    H. Kim Lyerly
    Frank R. Jones
    Cancer Immunology, Immunotherapy, 2010, 59 : 1131 - 1135
  • [27] Anti-tumor immunotherapy despite immunity to adenovirus using a novel adenoviral vector Ad5 [E1-, E2b-]-CEA
    Gabitzsch, Elizabeth S.
    Xu, Younong
    Balint, Joseph P., Jr.
    Hartman, Zachary C.
    Lyerly, H. Kim
    Jones, Frank R.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2010, 59 (07) : 1131 - 1135
  • [28] Safety and efficacy of Ad5/3-D24-GMCSF, a serotype 5/3 chimeric oncolytle adenovirus expressing granulocyte macrophage colony-stimulating factor (GM-CSF), in treatment of metastatic and refractory solid tumors.
    Hemminki, A.
    Pesonen, S.
    Koski, A.
    Cerullo, V.
    Escutenaire, S.
    Haavisto, E.
    Kangasniemi, L.
    Simula, P.
    Joensuu, T. K.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [29] The first lead fluorooxoborate PbB5O8F: achieving the coexistence of large birefringence and deep-ultraviolet cut-off edge
    Mutailipu, Miriding
    Zhang, Min
    Zhang, Bingbing
    Yang, Zhihua
    Pan, Shilie
    CHEMICAL COMMUNICATIONS, 2018, 54 (49) : 6308 - 6311
  • [30] A conditionally replicative adenovirus that codes for a TK-GFP fusion protein (Ad5Δ24TK-GFP) for evaluation of the potency of oncolytic virotherapy combined with molecular chemotherapy
    Hakkarainen, Tanja
    Hemminki, Akseli
    Curiel, David T.
    Wahlfors, Jarmo
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2006, 18 (04) : 751 - 759